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Various amino acid-derived compounds, for example, Nα-Cocoyl-L-arginine ethyl ester (CAE), alkyloxyhydroxylpropylarginine,
arginine cocoate, and cocoyl glycine potassium salt (Amilite), were examined for their virucidal activities against herpes simplex
virus type 1 and 2 (HSV-1 and HSV-2), inﬂuenza A virus (IAV), and poliovirus type 1 (PV-1) in comparison to benzalkonium
chloride (BKC) and sodium dodecylsulfate (SDS) as a cationic and anionic control detergent and also to other commercially
available disinfectants. While these amino acid-derived compounds were all eﬀective against HSV-1 and HSV-2, CAE and Amilite
were the most eﬀective. Thesetwocompoundswere, however,notaseﬀectiveagainstIAV,anotherenvelopedvirus,asagainstHSV.
Cytotoxicity of CAE was weak; at 0.012%, only 5% of the cells were killed under the conditions, in which 100% cells were killed by
eitherSDSorBKC.Inadditiontothesedirectvirucidaleﬀects,CAEinhibitedthevirusgrowthintheHSV-1-orPV-1-infectedcells
even at 0.01%. These results suggest a potential application of CAE as a therapeutic or preventive medicine against HSV superﬁcial
infection at body surface.
1.Introduction
Recently there has been an increasing necessity for a multi-
tude of preparedness against infectious diseases. Every year
we encounter emerging and reemerging infectious diseas-
es. While vaccination is a primary strategy to overcome
viral diseases [1], vaccines are not readily available for
many viruses and, even if available, not accessible for every
individual due to various reasons (e.g., cost, distribution,
and politics). Another compounding problem with virus
infection is that antiviral drugs are not available for many
viral diseases [2]. Disinfection at body surface, such as hand
sanitization, hasbeen an eﬀectivemeasurefortheprevention
against viral diseases and even applicable for the therapy of
certain viral diseases, provided that its tissue toxicity can be
tolerated [3].
A number of compounds, including organic solvents and
detergents, are known to inactivate viruses [4]. However,
most of these disinfectants are generally toxic to cells and
tissues, when come in contact with skins and in particular
mucosal surfaces, limiting their in vivo applications. We
have observed that aqueous arginine solution inactivates
various enveloped viruses, although relatively high arginine
concentration was required [5–10]. Such enhanced virus
inactivation by arginine was considered applicable for clear-
anceofcontaminatedvirusesinbiopharmaceuticalproducts.
Antiviral activity of arginine opened a window for topical
applications against superﬁcial infectious diseases where
both virucidal and antiviral activities might reduce the viral
load in the infected mucosal cells. Here we have undertaken
a systematic screening of amino acid derived compounds in
search for eﬀective, nontoxic antiviral and virucidal agents,
which can be used for both hand sanitization and superﬁcial
infections on body surface. Several available compounds
were tested for their eﬀects on inactivation of herpes simplex
viruses, inﬂuenza virus, and poliovirus and their toxic eﬀects2 Advances in Virology
on cultured cells and compared with the commercially
available known disinfectants.
2.MaterialsandMethods
2.1. Cells and Viruses. MDCK, HEp-2, and Vero cells were
grown in Eagle’s minimum essential medium (MEM) con-
taining 5% fetal bovine serum. Herpes simplex virus type 1,
strain F, (HSV-1), herpes simplex virus type 2, strain 186,
(HSV-2), inﬂuenza virus A/Aichi/68 (IAV) and poliovirus
type1(PV-1),Sabinvaccinestrain,wereusedthroughoutthe
experiments [11–13]. The viruses were propagated in Vero
cells (for HSV-1, HSV-2, and PV-1) in MEM supplemented
with 0.5% fetal bovine serum (FBS) or in MDCK cells
(for IAV) in MEM supplemented with 0.1% bovine serum
albumin(BSA)andacetylatedtrypsin(4μg/mL).Theviruses
werestoredat −80◦Cuntiluse.Theamountofeachviruswas
measured by a plaque assay as described previously [11–13].
2.2. Reagents. L-arginine hydrochloride (referred as
arginine), butyroyl-L-arginine (ButArg), Nα-cocoyl-
L-arginine ethyl ester (CAE), N-[3-alkyl(12,14)oxy-2-
hydroxypropyl]-L-arginine hydrochloride (Amisafe LMA-
60), L-arginine cocoate (Aminosoap AR-12), potassium
Nα-Cocoyl-L-glycinate (Amilite GCK-12K), benzalkonium
chloride (BKC), sodium dodecylsulfate (SDS), sodium
Nα-dodecanoylsarcosinate (LS), Chlorhexidine gluconate
(CHX), ethylalchol (EtOH), povidone iodine (PI), and
sodium hypochlorite (NaOCl) were of biochemical research
grade and kindly provided by Ajinomoto Co., Inc (Tokyo,
Japan). The compounds with trademark are used as ingre-
dients for cosmetic products. The pH of each solvent was
adjusted to the desired values using pH electrode type 6378
and pH meter type F-54 (Horiba; Kyoto, Japan). A pH meter
was manually calibrated every 2h during the preparation of
test solutions.
2.3. Assay for Virucidal Activity. All the starting materials
were stored on ice prior to the virus inactivation exper-
iments. An excess volume of solutions was mixed with
the virus stock so that both the pH and concentration of
the test solutions would not be aﬀected: that is, a 190μL
aliquot of the solutions received a 10μL aliquot of virus
preparations (approximately 107 ∼108 plaque-forming units
[PFU]/mL). This virus preparation was incubated at the
indicated temperature for 5min. After incubation, the test
mixtures were chilled in ice-water bath, and, immediately,
aliquots of these virus samples were 100-fold diluted with
ice-coldDulbecco’sphosphate-buﬀeredsaline (PBS)without
Ca2+ and Mg2+ containing 0.1% BSA for IAV or 0.5%
FBS for other viruses to stop the virus inactivation. The
viruses were further diluted to yield virus counts suitable
for measurements, and the number of infectious virus in
the treated preparation was measured by a plaque assay on
Vero (for HSV-1, HSV-2, and PV-1) or MDCK (for IAV)
cells. There was little virus inactivation in PBS, and hence
the amount of infectious virus in PBS was used as a control
count [14].
2.4. Eﬀe c to ft h eR e a g e n to nt h eM u l t i p l i c a t i o no ft h eV i r u s .
Monolayered cells in 35mm dishes were infected with the
virus at an indicated multiplicity of infection (MOI). The
infected cells were further incubated at 37◦C (for HSV-1,
HSV-2, and IAV) or 35.5◦C (for PV-1) for the indicated
period in the serum-free MEM (pH 7.4) containing 0.1%
BSAandtheindicatedconcentrationsofthetestcompounds.
The compounds were added at the onset of the incubation.
For the experiments with inﬂuenza virus, acetylated trypsin
(4μg/mL) was also added to the medium for the proteolytic
activation of virus infectivity. At the indicated time, the
culture medium was harvested and the amount of total
progeny virus in the culture was determined as described
previously [11–13].
2.5. Assay for the Cytotoxicity. Conﬂuent monolayers of Vero
cells were incubated in 0.85% sodium chloride solution (pH
5.5) containing 20mM MES (2-Morpholinoethanesulfonic
acid) and varying concentrations of each test compound
at room temperature for 15min. To determine the extents
of cell death, monolayered cells were trypsinized to obtain
single cell suspension. After the addition of MEM containing
10% calf serum to the suspension to neutralize the trypsin
and to stabilize the cells, the number of the living or dead
cells was determined by a dye exclusion method with trypan
blue as described previously [15].
3. Results and Discussion
3.1.EﬀectofAminoAcidDerivedCompoundsontheInfectivity
o fD N Aa n dR N AV i r u s e s .We examined the virucidal
activity of arginine and amino acid derived compounds (i.e.,
0.5M arginine, 0.5M ButArg, 0.2% CAE, 0.2% Amisafe,
0.2% Aminosoap, and 0.2% Amilite) on viruses of three
completelydiﬀerentkinds;thatis,HSV-1andHSV-2(Family
of Herpesviridae), IAV (Family of Orthomyxoviridae), and
PV-1 (Family of Picornaviridae). Both HSVs and IAV are
large enveloped viruses and need the cell nucleus for the
virus multiplication: the former has a double-stranded DNA
genome, and the latter has a segmented negative-stranded
R N Ag e n o m e[ 16, 17]. In contrast to the viruses of these two
virus families, PV-1 is a small nonenveloped virus carrying
a positive-stranded RNA as a genome and replicates in the
cytoplasm of the infected cells [18].
Figure 1 shows the eﬀects of these compounds on the
infectivity of HSV-1, when the virus was incubated at 30◦C
for 5min. As a control, the virus was incubated in PBS
and the relative residual infectivity for each compound was
calculated by dividing the number of the infectious virus in
the test solutions by that of the PBS control. As shown in
Figure 1, HSV-1 was sensitive to these compounds except
for Amisafe; the virus infectivity decreased below or near
the detection level (10−5 of the control). In the case of
Amisafe, the decrease in the virus infectivity was marginally
lessthanthatincubatedinthePBS.Theseresultsclearlyshow
that arginine and amino acid derived compounds (except
Amisafe)caneﬃcientlyinactivateHSV-1,anenvelopedDNA
virus, under the experimental conditions. Although pH, ionAdvances in Virology 3
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Figure 1: Inactivation of HSV-1. The virus was incubated in the
solution indicated below for 5min at 30◦C. Number of infectious
v i r u sw a sd e t e r m i n e db yap l a q u ea s s a yo nV e r oc e l l sa f t e rt h e
incubation and was normalized to that incubated in PBS. Arginine
(0.5M at pH 4.0 in 10mM citrate), ButArg (0.5M in pH 4.0 in
10mM citrate), CAE (0.2% in 5mM citrate and 0.15M NaCl at
pH 4.8), Amisafe (0.2% in 5mM citrate and 0.15M NaCl at pH
4.8), Aminosoap (0.2% in 5mM citrate at pH 7.0), Amilite (0.2%
in 5mM citrate at pH 8.0), BKC (0.1% in 5mM citrate at pH 7.0),
SDS (0.2% in 5mM citrate at pH 7.0), LS (0.2% in 5mM citrate
at pH 7.0), CHX (0.5% at pH 6.0), EtOH (70% in 5mM citrate at
pH 7.0), PI (0.23% in 5mM citrate at pH 3.5), NaOCl (100ppm in
5mM phosphate at pH 7.0), and PBS (pH 7.4).
species, or ionic strength of the solution can aﬀect the degree
of virus inactivation [14], we have shown before that HSV-
1 is relatively stable above pH 4.8 and the eﬀects of pH 4.0
alone are much weaker than the combined eﬀects of the pH
and arginine or ButArg [5, 6]. The results were compared
with commercial disinfectants (i.e., 0.1% BKC, 0.2% SDS,
0.2% LS, 0.5% CHX, 70% EtOH, 0.23% PI, and 100ppm
NaOCl). These commercial disinfectants also showed strong
virus inactivation on HSV-1 (Figure 1), although the eﬀect
of PI may be entirely due to the low pH (i.e., pH 3.5).
Enveloped viruses are known to be sensitive to detergents,
which can perturb and solubilize lipid bilayers in the viral
envelope. In agreement with this, HSV-2, another human
herpesvirus of diﬀerent serotype and pathogenicity, also
showed a similar sensitivity proﬁle to these amino acid
derivatives and disinfectants (data not shown).
Next, we tested these compounds in Figure 1 against
IAV, an enveloped virus of another virus family. As shown
in Figure 2 (white columns), the proﬁle was quite diﬀerent
from that observed for HSV-1 (and HSV-2). ButArg, CAE,
Aminosoap, BKC, EtOH, PI, and NaOCl reduced the IAV
infectivity below the detection level (10−5 of the control).
Arginine, Amisafe, Amilite, SDS, LS, and CHX showed a
varying degree of virucidal activities, with Amisafe being
signiﬁcantly less eﬀective, similar to its eﬀect on HSV-1, and
with CHX being least eﬀective (white columns in Figure 2).
We have shown before that the pH proﬁle of IAV inactivation
is complex [14] and, at least, a part of inactivation by low
pH samples (arginine, ButArg, and PI) is due to the pH,
but that the pH alone cannot explain the strong inactivation
by arginine and ButArg [5, 6]. Interestingly, the addition
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Figure 2: Inactivation of IAV. See the legend to Figure 1.B l a c ka n d
white bars represent the results in the presence or absence of 0.1%
BSA.
of 0.1% BSA resulted in suppression, at least partially, of
IAV inactivation by CAE, Amisafe, Amilite, BKC, SDS, and
LS (black columns in Figure 2). This is unlikely due to the
interactionofBSAwith thevirus,asit did not aﬀectthevirus
infectivity in PBS. It is most likely due to the ability of BSA to
bind fatty acids [19] and hence these compounds that have
nonpolar moieties.
The observed eﬀects of these compounds on IAV suggest
the potential mechanism of inactivation. Comparison of
arginine, ButArg, CAE, Aminosoap, BKC, EtOH, PI, and
NaOCl, which showed strong virucidal eﬀects on this
virus, demonstrates no distinct pattern with compound
structure. Arginine and ButArg are known to suppress
protein-protein interactions, probably through their ability
to interact with proteins [20–22]. CAE, Aminosoap, and
BKC have surfactant properties. EtOH is an organic solvent.
These compounds can interact with not only proteins, but
also lipid membranes. PI and NaOCl are strong oxidants
and can interact with most components of virus particles.
On the contrary, there appears to be a unique structure
pattern for less active compounds, that is, Amisafe, Amilite,
SDS, LS, and CHX. These are all detergents, meaning that
detergent-like properties are insuﬃcient for the eﬀective
virus inactivation. However, these detergents are eﬀective
againstHSV-1,demonstratingthatthevirucidaleﬀectiveness
is virus dependent. In contrast to these enveloped viruses,
poliovirus was resistant to inactivation by these amino
acid derived compounds, as only negligible degree of the
inactivation was observed (Figure 3). Even combination of
pH 4.0 and arginine or ButArg was insuﬃcient. The lack
of sensitivity of PV-1 may suggest that inactivation of
HSV-1 (Figure 1)a n dI A V( Figure 2) by these compounds
requires the presence of lipid envelope on the structure
of target viruses. It should be noteworthy that although
these compounds appear to act on lipids, it does not
necessarily mean solubilization of envelope lipid bilayer. The
concentrations of the detergents used in these experiments
(0.2%) are below critical micelle concentrations (CMCs).
Although the CMCs of ionic detergents are generally aﬀected
by the pH of detergent solutions, they are considered to4 Advances in Virology
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Figure 3: Inactivation of poliovirus. See the legend to Figure 1.
be in the range of ∼10mM (approximately 0.4%) under
the experimental conditions. Below CMC, detergents are
unlikely capable of destroying membrane structure.
Among these compounds, CAE and Aminosoap showed
a marked virucidal activity. Considering that CAE has been
reported to have bacteriocidal activity [23], we further
characterized the virucidal activity of CAE.
3.2. Characterization of Virucidal Activity of CAE. Figure 4
shows the eﬀects of CAE concentration on the inactivation
of HSV-1, HSV-2, IAV, and PV-1. As CAE was more soluble
at acidic pH, we used pH 5.0 in these experiments. This
pH alone caused little inactivation for HSVs (less than 20%
inactivation, if any) and PV-1 (almost no inactivation), but a
signiﬁcantinactivationforIAV(50 ∼70%inactivation)[14].
This is probably due to acid-induced conformational change
of HA spike proteins present in IAV envelope [17]. Under
the concentration range (0.001 to 0.04% CAE), PV-1 showed
only a marginal loss of the infectivity, while IAV showed a
small, but signiﬁcant (60% decrease at 0.04% CAE), decrease
ininfectivitywithincreasingCAEconcentrations.Incontrast
to these two viruses, both HSV-1 and HSV-2 showed a
sharp decrease in infectivity, leading to 104-fold reduction
at 0.02% CAE for HSV-1 and ∼103-fold reduction at 0.01%
CAE for HSV-2. Although both HSV-1 and HSV-2 belong
to the same virus family, HSV-2 showed a signiﬁcantly
strongerinactivationthanHSV-1atlowCAEconcentrations.
This virucidal activity of CAE was slightly, but signiﬁcantly,
enhanced by lowering the pH of the test solutions to 4.0
or 4.5; for example, the inactivation of HSV-1 or HSV-2 at
0.005% CAE was only marginal at pH 5.0, but was enhanced
10-fold (for HSV-1) or 100-fold (for HSV-2) at pH 4.0 at the
same CAE concentration.
To further characterize the virucidal eﬀects of CAE, it
was compared with SDS, an anionic detergent, and BKC,
a cationic detergent, at neutral pH. Figure 5 shows such
a comparison of virucidal activities against HSV-2. Both
B K Ca n dS D Ss h o w e dm a r k e de ﬀects (more than two-log
reduction) on HSV-2 infectivity even at low concentrations,
for example, at 0.002% and 0.003%, respectively, while CAE
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Figure 4: Inactivation of viruses by CAE. The viruses were
incubated at 20◦C for 5min in 10mM citrate buﬀer (pH 5.0)
containing 0.15M sodium chloride and varying concentrations of
CAE. Number of infectious virus was determined by a plaque
assay after the incubation and was normalized to that incubated in
PBS (pH 7.4). Circles ( )f o rH S V - 1 ;b l a c kc i r c l e( •)f o rH S V - 2 ;
triangles ( ) for IAV; squares ()f o rP V - 1 .
required higher concentrations to achieve a similar level of
inactivation under these conditions.
3.3. Cytotoxic Eﬀects of the Reagents. The above three com-
pounds were then compared for cell toxicity. As shown in
Figure 6, BKC showed a strong cytocidal eﬀect. When the
monolayers of Vero cells were incubated in isotonic buﬀer
solution in the presence of various concentrations of CAE,
BKC, and SDS for 15min at room temperature and numbers
of dead and alive cells were determined by dye exclusion
test with trypan blue, BKC showed a drastic increase in the
number of dead cells at the concentration above 0.002%. At
the concentration required for the eﬀective virucidal eﬀect
(0.003%), BKC killed more than 10% of the cells. In contrast
to BKC, cell death by SDS and CAE occurred at 2.5- and
10-fold higher concentrations, indicating their lower cell
toxicity. It should be noted that SDS solubilized plasma
membrane of the cells at the cytotoxic concentrations while
CAE or BKC did not (data not shown), leading to a possible
underestimation of the fraction of dead cells in the SDS-
treated dishes. The results suggest that at 0.01% CAE, about
2%ofthecellswerekilledbythecompound(Figure 6),while
more than 99% of the virus was inactivated (Figure 5).
3.4. Inhibition of Virus Multiplication by CAE. The results in
Figures 1–5 show in vitro virus inactivation. Whether the
same compounds can yield a reduced virus multiplication
in in vivo experiments was then examined by treating the
infected cells with them. Figure 7 shows the results of CAE
and BKC on the relative virus yields of HSV-1 (circle) orAdvances in Virology 5
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Figure 5: Eﬀects of CAE, BKC, and SDS on the infectivity of
HSV-2. HSV-2 was incubated in PBS (pH 7.4) containing varying
concentrations of each compound at 30◦C for 5 min. The amounts
of infectious progeny viruses were determined by a plaque assay
after the incubation and were normalized to that incubated in PBS
(pH 7.4). Circles ( ) for CAE; triangles ( )f o rB K C ;s q u a r e s( )
for SDS.
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Figure 6: Eﬀect of CAE, BKC, and SDS on the cell viability.
Conﬂuent monolayers of Vero cells were incubated in 0.85%
sodium chloride solution (pH 5.5) containing 20mM MES and
varying concentrations of each compound at room temperature
for 15min. The treated cells were trypsinized to obtain a single
cell suspension and the amounts of the live and dead cells in each
culture were determined by a dye exclusion test with trypan blue.
Circles ( ) for CAE; triangles ( )f o rB K C ;s q u a r e s( ) for SDS.
PV-1 (triangle), when the virus-infected cells were incubated
in the medium containing varying concentration of CAE
(open symbol) or BKC(closed symbol): note that the highest
concentrations used are still below the concentrations used
forvirusinactivation.Themultiplicationofthesetwoviruses
was much more strongly suppressed by BKC than CAE.
However, their eﬀects on these two viruses were diﬀerent.
Namely, CAE suppressed more strongly the virus yield of
PV-1 than HSV-1, opposite to BKC. Comparison of the
resultsinFigure 6suggeststhatthesuppressionofthesevirus
multiplications by CEA or BKC was not due to the death of
the infected cells. These results show that both BKC and CEA
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Figure 7: Eﬀect of CAE and BKC on the virus multiplication.
ConﬂuentmonolayersofHEp-2cellswereinfectedwithHSV-1( ,
•)atanMOIof14orPV-1( ,)atanMOIof9.Theinfectedcells
were incubated for overnight in the medium containing varying
concentrations of CAE ( ,  )o rB K C( •, )a t3 7 ◦Cf o rH S V - 1o r
at 35.5◦C for PV-1. At the end of infection (20h after infection for
HSV-1 and 16 h after infection for PV-1), the amounts of infectious
progeny viruses were determined and were normalized to the virus
yield in the absence of these compounds.
inhibit the multiplication of two viruses widely diﬀerent in
the way the replication and transcription of the viral genome
occur (i.e., in the nucleus or in the cytoplasm of the infected
cells). It is interesting to note that BKC and CAE, which were
both ineﬀective even at 0.1 and 0.2% in inactivating PV-1,
can suppress the growth of the same virus in the infected
cells. It is evident that the decreased virus yield in infected
cells for PV-1 (and perhaps HSV-1) is not simply due to the
virus inactivation.
Generally, virus-inactivating agents (disinfectants) show
toxicity to cells and tissues, limiting their applications.
We have undertaken a systematic screening of amino acid
derived compounds in search for eﬀective, nontoxic virus-
inactivating agents and found that, against HSV-1 and HSV-
2, CAE has notable activities to inactivate the infectivity
of extracellular virus particles and to suppress the virus
multiplication in the infected cells at the concentration with
tolerable cytotoxic eﬀect. These results may support a future
potential application of CAE as a therapeutic or preventive
medicine against HSV superﬁcial infection at body surface,
such as herpetic keratitis and genital herpes.
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